[Federal Register Volume 61, Number 14 (Monday, January 22, 1996)]
[Notices]
[Pages 1603-1604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-650]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 8, 1995, Organix 
Inc., 65 Cummings Park, Woburn, Massachusetts 01801, made application 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................................          I 
Morphine (9300).............................................         II 
------------------------------------------------------------------------


[[Page 1604]]


    The firm plans to manufacture tetrahydrocannabinols and a 
derivative of morphine for use in diagnostic kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than March 22, 1996.

    Dated: December 22, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-650 Filed 1-19-96; 8:45 am]
BILLING CODE 4410-09-M